Results 211 to 220 of about 74,377 (332)

Bidirectional Alterations of Hippocampal Cannabinoid 1 Receptors and Their Endogenous Ligands in a Rat Model of Alcohol Withdrawal and Dependence [PDF]

, 2007
Somsak Mitrirattanakul, Héctor E. López‐Valdés, Jing Liang, Yoshizo Matsuka, Ken Mackie, Kym F. Faull, Igor Spigelman   +6 more
openalex   +1 more source

Effects of cannabidiol in alcohol use disorder patients with and without co‐occurring post‐traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof‐of‐concept trials

Alcohol, Clinical and Experimental Research, Volume 50, Issue 1, January 2026.
Two small placebo‐controlled trials evaluated the effects of cannabidiol (CBD) in patients with alcohol use disorder (AUD), with and without co‐occurring post‐traumatic stress disorder (PTSD). CBD was rapidly absorbed and generally well tolerated in dosages of up to 1200 mg/day. Both treatment groups showed large reductions in drinking.
Michael P. Bogenschutz, Esther Blessing, Danielle Dgheim, Dayeon Cho, Jun Zhang, Eugene M. Laska, Charles R. Marmar   +6 more
wiley   +1 more source

Kinin B1 receptor mediates acute cardiovascular and neural responses following cannabinoid receptor 1 activation in conscious male mice. [PDF]

Physiol Rep
Theobald D, Ahmed SA, Abdel-Rahman AA, Sriramula S.   +3 more
europepmc   +1 more source

Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1

, 2014
Rebecca L. Kow, Kelly Jiang, Alipi V. Naydenov, Joshua H. Le, Nephi Stella, Neil M. Nathanson   +5 more
openalex   +2 more sources

Cannabinoid receptors in submandibular acinar cells: functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling [PDF]

, 2012
Olga Kopach, Juliana Vats, Olga Netsyk, Nana Voitenko, Andrew J. Irving, Наталія Федірко   +5 more
openalex   +1 more source

CONTROL OF A HIPPOCAMPAL RECURRENT EXCITATORY CIRCUIT BY CANNABINOID RECEPTOR-INTERACTING PROTEIN GAP43

, 2023
Irene B. Maroto, Carlos Costas‐Insua, Coralie Berthoux, Estefanía Moreno, Andrea Ruiz-Calvo, Carlos Montero-Fernández, Andrea Macías‐Camero, Ricardo Martín, Nuria García-Font, José Sánchez‐Prieto, Giovanni Marsicano, Luigi Bellocchio, Enric I. Canela, Vicent Casadó, Ismael Galve‐Roperh, Ángel Núñez, David Fernández de Sevilla, Ignacio Rodríguez‐Crespo, Pablo E. Castillo, Manuel Guzmán   +19 more
openalex   +1 more source

Neuroprotective effects of G9a inhibition and cannabinoid receptor activation in Alzheimer's disease through a pharmacological approach. [PDF]

Neurotherapeutics
Bellver-Sanchis A, Ribalta-Vilella M, Lillo J, Ortuño-Sahagún D, Franco R, Pallàs M, Navarro G, Griñán-Ferré C.   +7 more
europepmc   +1 more source

Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance

Kelsey G. Guenther, Xiaoyan Lin, Zhili Xu, Alexandros Makriyannis, Julián Romero, Cecilia J. Hillard, Ken Mackie, Andrea G. Hohmann   +7 more
openalex   +1 more source

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Cannabidiol (CBD) use has increased in America due to its widespread availability. Cannabidiol is metabolized by multiple polymorphic enzymes including CYP3A, CYP2C9, and CYP2C19. We sought to evaluate the genotype‐specific adverse events and pharmacokinetic profiles of cannabidiol, 7‐OH cannabidiol (an active metabolite), and 7‐COOH ...
Jumar Etkins, Gerald C. So, Jessica Bo Li Lu, Sachiko Koyama, Debora L. Gisch, Ricardo Melo Ferreira, Ying‐Hua Cheng, Kelsey McClara, Joshua Jun, Matthew Miller, Zeruesenay Desta, Michael T. Eadon   +11 more
wiley   +1 more source

In vitro CB₁ receptor activity of halogenated indazole synthetic cannabinoid receptor agonists. [PDF]

Arch Toxicol
Green H, McKenzie C, Hamra E, Rautio T, Wu X, Juneskog E, Sandblom R, Monti MC, Persson M, Norman C.   +9 more
europepmc   +1 more source